127 related articles for article (PubMed ID: 2202111)
1. Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results.
Isoniemi H; Eklund B; Höckerstedt K; Korsbäck C; Salmela K; von Willebrand E; Häyry P; Ahonen J
Transplant Proc; 1990 Aug; 22(4):1365-6. PubMed ID: 2202111
[No Abstract] [Full Text] [Related]
2. A controlled trial of triple therapy in renal transplantation.
Salaman JR; Griffin PJ; Ross WB; Williams JD
Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061
[No Abstract] [Full Text] [Related]
3. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
[No Abstract] [Full Text] [Related]
4. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
[No Abstract] [Full Text] [Related]
5. A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients.
Restifo AC; Petrie JJ; Rigby RJ; Hardie IR; Jacob CK; Russ GR; Mathew TH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1604-5. PubMed ID: 2652522
[No Abstract] [Full Text] [Related]
6. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
[No Abstract] [Full Text] [Related]
7. Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function.
Tegzess AM; van Son WJ; de Maar EF; Beelen JM; Sluiter WJ; Huisman RM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1635-7. PubMed ID: 2652534
[No Abstract] [Full Text] [Related]
8. A prospective study on the influence of cyclosporine and azathioprine on renal allograft survival and function.
Henny FC; Kootte AM; van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
Transplant Proc; 1987 Feb; 19(1 Pt 3):1853-5. PubMed ID: 3079050
[No Abstract] [Full Text] [Related]
9. A controlled trial of azathioprine in combination with cyclosporine in cadaveric renal transplantation.
Griffin PJ; Ferguson CJ; Ross WB; Salaman JR
Transplant Proc; 1990 Aug; 22(4):1369. PubMed ID: 2202112
[No Abstract] [Full Text] [Related]
10. Adrenal function as an index of the immunosuppressive activity of glucocorticoids (prednisolone) in renal allograft recipients.
Kozaki M; Hirano T; Oka K
Transplant Proc; 1987 Feb; 19(1 Pt 3):2237-9. PubMed ID: 3079076
[No Abstract] [Full Text] [Related]
11. Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation.
Osakabe T; Uchida H; Masaki Y; Yokota K; Sato K; Nakayama Y; Ohkubo M; Kumano K; Endo T; Watanabe K
Transplant Proc; 1989 Feb; 21(1 Pt 2):1598-600. PubMed ID: 2652520
[No Abstract] [Full Text] [Related]
12. Dual vs triple immunosuppressive therapy: equally safe and effective in kidney transplantation?
Albrechtsen D; Flatmark A; Brynger H; Frødin L; Groth CG; Persson N
Transplant Proc; 1991 Aug; 23(4):2206. PubMed ID: 1871845
[No Abstract] [Full Text] [Related]
13. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
14. Frequency of allograft renal vascular thrombosis under three immunosuppressive regimens at a single institution.
Gruber SA; Chavers B; Payne WD; Fryd DS; Canafax DM; Simmons RL; Najarian JS; Matas A
Transplant Proc; 1989 Feb; 21(1 Pt 2):2139-40. PubMed ID: 2652690
[No Abstract] [Full Text] [Related]
15. Comparison of three immunosuppressive regimens in high-risk patients: immunologic aspects.
Renna Molajoni E; Bachetoni A; Cinti P; Sallustio F; Rossi M; Pretagostini R; Orlandini A; Berloco P; Alfani D; Cortesini R
Transplant Proc; 1987 Feb; 19(1 Pt 3):1978-80. PubMed ID: 3079064
[No Abstract] [Full Text] [Related]
16. Triple therapy improves the survival of cadaver renal allografts affected by acute tubular necrosis.
Bakran A; Johnson RW; Dyer PA; Mallick NP; Gokal R
Transplant Proc; 1989 Feb; 21(1 Pt 2):1278-9. PubMed ID: 2652423
[No Abstract] [Full Text] [Related]
17. Randomised trial of conversion from cyclosporin to azathioprine at one year after renal transplantation.
Watson MA; Briggs JD; Junor BJ; McMillan MA; Macpherson SG; Murray G; Stewart RM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1583-4. PubMed ID: 2652514
[No Abstract] [Full Text] [Related]
18. Triple therapy.
Slapak M; Digard N; Wise M; Setakis N
Transplant Proc; 1991 Aug; 23(4):2186-8. PubMed ID: 1871837
[No Abstract] [Full Text] [Related]
19. Does the addition of azathioprine (Aza) to CyA monotherapy after a first rejection prevent a second rejection episode in kidney transplant patients?
Hourmant M; Taupin JL; Leymerigie F; Cantarovich D; Soulillou JP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1589-90. PubMed ID: 2652517
[No Abstract] [Full Text] [Related]
20. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
[No Abstract] [Full Text] [Related]
[Next] [New Search]
